Carlson College of Veterinary Medicine

C. Lupfer, Patton, K. M., and Pastey, M., “Treatment of human respiratory syncytial virus infected Balb/C mice with the proteasome inhibitor bortezomib (Velcade, PS-341) results in increased inflammation and mortality.”, Toxicology, vol. 268, no. 1-2, pp. 25-30, 2010.

M. Pastey and Samal, S. K., “Structure and sequence comparison of bovine respiratory syncytial virus fusion protein.”, Virus research, vol. 29, no. 2, pp. 195-202, 1993.

M. Pastey and Samal, S. K., “Role of individual N-linked oligosaccharide chains and different regions of bovine respiratory syncytial virus fusion protein in cell surface transport.”, Archives of virology, vol. 142, no. 11, pp. 2309-20, 1997.

S. K. Samal and Pastey, M., “Role of envelope glycoproteins of bovine respiratory syncytial virus in cell fusion.”, Indian journal of biochemistry & biophysics, vol. 34, no. 1-2, pp. 181-5, 1997.

M. Pastey, Gower, T. L., Spearman, P. W., Crowe, J. E., and Graham, B. S., “A RhoA-derived peptide inhibits syncytium formation induced by respiratory syncytial virus and parainfluenza virus type 3.”, Nature medicine, vol. 6, no. 1, pp. 35-40, 2000.

M. Maselko, Ward, C., and Pastey, M., “A RhoA-derived peptide inhibits human immunodeficiency virus-1 entry in vitro.”, Current HIV research, vol. 9, no. 1, pp. 1-5, 2011.

T. L. Gower, Pastey, M., Peeples, M. E., Collins, P. L., McCurdy, L. H., Hart, T. K., Guth, A., Johnson, T. R., and Graham, B. S., “RhoA signaling is required for respiratory syncytial virus-induced syncytium formation and filamentous virion morphology.”, Journal of virology, vol. 79, no. 9, pp. 5326-36, 2005.

M. Pastey, Crowe, J. E., and Graham, B. S., “RhoA interacts with the fusion glycoprotein of respiratory syncytial virus and facilitates virus-induced syncytium formation.”, Journal of virology, vol. 73, no. 9, pp. 7262-70, 1999.

S. K. Samal, Pastey, M., McPhillips, T., Carmel, D. K., and Mohanty, S. B., “Reliable confirmation of antibodies to bovine respiratory syncytial virus (BRSV) by enzyme-linked immunosorbent assay using BRSV nucleocapsid protein expressed in insect cells.”, Journal of clinical microbiology, vol. 31, no. 12, pp. 3147-52, 1993.

M. Pastey and Samal, S. K., “Nucleotide sequence analysis of the non-structural NS1 (1C) and NS2 (1B) protein genes of bovine respiratory syncytial virus.”, The Journal of general virology, vol. 76 ( Pt 1), pp. 193-7, 1995.

K. A. Reese, Lupfer, C., Johnson, R. C., Mitev, G. M., Mullen, V. M., Geller, B. L., and Pastey, M., “A Novel Lactococcal Vaccine Expressing a Peptide from the M2 Antigen of H5N2 Highly Pathogenic Avian Influenza A Virus Prolongs Survival of Vaccinated Chickens.”, Veterinary medicine international, vol. 2013, p. 316926, 2013.

Q. Ge, Pastey, M., Kobasa, D., Puthavathana, P., Lupfer, C., Bestwick, R. K., Iversen, P. L., Chen, J., and Stein, D. A., “Inhibition of multiple subtypes of influenza A virus in cell cultures with morpholino oligomers.”, Antimicrobial agents and chemotherapy, vol. 50, no. 11, pp. 3724-33, 2006.

C. Lupfer, Stein, D. A., Mourich, D. V., Tepper, S. E., Iversen, P. L., and Pastey, M., “Inhibition of influenza A H3N8 virus infections in mice by morpholino oligomers.”, Archives of virology, vol. 153, no. 5, pp. 929-37, 2008.

C. Lupfer, Besnouin, D., Tepper, S. E., Maselko, M., Patton, K. M., and Pastey, M., “Increased Survivorship and Altered Cytokine Profile from Treatment of Influenza A H1N1-Infected Mice with Ekybion: A Drug Complex of Natural Extracts and Inorganic Compounds.”, Evidence-based complementary and alternative medicine : eCAM, vol. 2011, p. 192079, 2011.

E. C. McKenzie, Lupfer, C., Banse, H., Hinchcliff, K., Love, S., Nelson, S., Davis, M., Payton, M., and Pastey, M., “Hypogammaglobulinemia in racing Alaskan sled dogs.”, Journal of veterinary internal medicine / American College of Veterinary Internal Medicine, vol. 24, no. 1, pp. 179-84, 2010.

S. Mohapatra, Park, S. J., Boyapalle, S., Pastey, M., Graham, B. S., and Blanck, G., “Human respiratory syncytial virus reduces the number of cells in S-phase and increases GADD153 expression in HEp-2 cells.”, Acta virologica, vol. 53, no. 3, pp. 207-11, 2009.

C. Lupfer and Pastey, M., “Decreased replication of human respiratory syncytial virus treated with the proteasome inhibitor MG-132.”, Virus research, vol. 149, no. 1, pp. 36-41, 2010.

S. K. Samal, Pastey, M., McPhillips, T. H., and Mohanty, S. B., “Bovine respiratory syncytial virus nucleocapsid protein expressed in insect cells specifically interacts with the phosphoprotein and the M2 protein.”, Virology, vol. 193, no. 1, pp. 470-3, 1993.

M. Pastey and Samal, S. K., “Baculovirus expression of the fusion protein gene of bovine respiratory syncytial virus and utility of the recombinant protein in a diagnostic enzyme immunoassay.”, Journal of clinical microbiology, vol. 36, no. 4, pp. 1105-8, 1998.

M. Pastey and Samal, S. K., “Analysis of the bovine respiratory syncytial virus fusion protein (F) using monoclonal antibodies.”, Veterinary microbiology, vol. 58, no. 2-4, pp. 175-85, 1997.

M. Pastey and Samal, S. K., “Analysis of bovine respiratory syncytial virus envelope glycoproteins in cell fusion.”, The Journal of general virology, vol. 78 ( Pt 8), pp. 1885-9, 1997.